Your browser doesn't support javascript.
loading
ANK2 loss-of-function variants are associated with epilepsy, and lead to impaired axon initial segment plasticity and hyperactive network activity in hiPSC-derived neuronal networks.
Teunissen, Maria W A; Lewerissa, Elly; van Hugte, Eline J H; Wang, Shan; Ockeloen, Charlotte W; Koolen, David A; Pfundt, Rolph; Marcelis, Carlo L M; Brilstra, Eva; Howe, Jennifer L; Scherer, Stephen W; Le Guillou, Xavier; Bilan, Frédéric; Primiano, Michelle; Roohi, Jasmin; Piton, Amelie; de Saint Martin, Anne; Baer, Sarah; Seiffert, Simone; Platzer, Konrad; Jamra, Rami Abou; Syrbe, Steffen; Doering, Jan H; Lakhani, Shenela; Nangia, Srishti; Gilissen, Christian; Vermeulen, R Jeroen; Rouhl, Rob P W; Brunner, Han G; Willemsen, Marjolein H; Nadif Kasri, Nael.
Afiliación
  • Teunissen MWA; Department of Neurology, Maastricht University Medical Center, Maastricht, HX 6229, The Netherlands.
  • Lewerissa E; Academic Center for Epileptology Kempenhaeghe/Maastricht University Medical Center, Heeze 5591 VE, The Netherlands.
  • van Hugte EJH; Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition, and Behaviour, Nijmegen, HB 6500, the Netherlands.
  • Wang S; Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition, and Behaviour, Nijmegen, HB 6500, the Netherlands.
  • Ockeloen CW; Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition, and Behaviour, Nijmegen, HB 6500, the Netherlands.
  • Koolen DA; Department of Human Genetics, Radboud University Medical Center, Nijmegen, GA 6525, the Netherlands.
  • Pfundt R; Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition, and Behaviour, Nijmegen, HB 6500, the Netherlands.
  • Marcelis CLM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, GA 6525, the Netherlands.
  • Brilstra E; Department of Human Genetics, Radboud University Medical Center, Nijmegen, GA 6525, the Netherlands.
  • Howe JL; Department of Human Genetics, University Medical Center Utrecht, Utrecht, CX 3584, The Netherlands.
  • Scherer SW; The Centre for Applied Genomics and Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
  • Le Guillou X; The Centre for Applied Genomics and Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
  • Bilan F; McLaughlin Centre and Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 3H7, Canada.
  • Primiano M; Department of Medical Genetics, Centre Hospitalier Universitaire de Poitiers, Poitiers 86000, France.
  • Roohi J; Department of Medical Genetics, Centre Hospitalier Universitaire de Poitiers, Poitiers 86000, France.
  • Piton A; Laboratory of Experimental and Clinical Neurosciences University of Poitiers, INSERM U1084, Poitiers 86000, France.
  • de Saint Martin A; Department of Clinical Genetics, Morgan Stanley Children's Hospital of New York-Presbytarian, New York, NY, 10032, USA.
  • Baer S; Department of Clinical Genetics, Morgan Stanley Children's Hospital of New York-Presbytarian, New York, NY, 10032, USA.
  • Seiffert S; Clinical Genetics, Kaiser Permanente Mid-Atlantic Permanente Medical Group, Rockville, MD 20852, USA.
  • Platzer K; Laboratoire de Diagnostic Génétique, Institut de Génétique Médicale d'Alsace (IGMA), Hôspitaux Universitaire de Strasbourg, Strasbourg, BP 426 67091, France.
  • Jamra RA; Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch 67400, France.
  • Syrbe S; Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch 67400, France.
  • Doering JH; Department of Pediatric Neurology, Strasbourg University Hospital, Hôspital de Hautepierre, Strasbourg, BP 426 67091, France.
  • Lakhani S; Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch 67400, France.
  • Nangia S; Department of Pediatric Neurology, Strasbourg University Hospital, Hôspital de Hautepierre, Strasbourg, BP 426 67091, France.
  • Gilissen C; Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, Tuebingen, 72076, Germany.
  • Vermeulen RJ; Institute of Human Genetics, University Medical Center Leipzig, Leipzig 04103, Germany.
  • Rouhl RPW; Institute of Human Genetics, University Medical Center Leipzig, Leipzig 04103, Germany.
  • Brunner HG; Division of Paediatric Epileptology, Centre for Paediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg 69120, Germany.
  • Willemsen MH; Division of Paediatric Epileptology, Centre for Paediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg 69120, Germany.
  • Nadif Kasri N; Department of neurogenetics, Weill Cornell Medicine, Brain and Mind Research Institute, New York, NY, 10065, USA.
Hum Mol Genet ; 32(14): 2373-2385, 2023 07 04.
Article en En | MEDLINE | ID: mdl-37195288
ABSTRACT

PURPOSE:

To characterize a novel neurodevelopmental syndrome due to loss-of-function (LoF) variants in Ankyrin 2 (ANK2), and to explore the effects on neuronal network dynamics and homeostatic plasticity in human-induced pluripotent stem cell-derived neurons.

METHODS:

We collected clinical and molecular data of 12 individuals with heterozygous de novo LoF variants in ANK2. We generated a heterozygous LoF allele of ANK2 using CRISPR/Cas9 in human-induced pluripotent stem cells (hiPSCs). HiPSCs were differentiated into excitatory neurons, and we measured their spontaneous electrophysiological responses using micro-electrode arrays (MEAs). We also characterized their somatodendritic morphology and axon initial segment (AIS) structure and plasticity.

RESULTS:

We found a broad neurodevelopmental disorder (NDD), comprising intellectual disability, autism spectrum disorders and early onset epilepsy. Using MEAs, we found that hiPSC-derived neurons with heterozygous LoF of ANK2 show a hyperactive and desynchronized neuronal network. ANK2-deficient neurons also showed increased somatodendritic structures and altered AIS structure of which its plasticity is impaired upon activity-dependent modulation.

CONCLUSIONS:

Phenotypic characterization of patients with de novo ANK2 LoF variants defines a novel NDD with early onset epilepsy. Our functional in vitro data of ANK2-deficient human neurons show a specific neuronal phenotype in which reduced ANKB expression leads to hyperactive and desynchronized neuronal network activity, increased somatodendritic complexity and AIS structure and impaired activity-dependent plasticity of the AIS.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epilepsia / Células Madre Pluripotentes Inducidas / Segmento Inicial del Axón Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Hum Mol Genet Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epilepsia / Células Madre Pluripotentes Inducidas / Segmento Inicial del Axón Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Hum Mol Genet Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos